When a person is in the intensive care unit with severe respiratory failure, every hour matters. These patients often cannot breathe on their own and must rely on a machine called a ventilator to move air into their lungs. Doctors are constantly looking for ways to clear mucus and secretions from the lungs so that patients can be taken off these machines faster. Two specific treatments, carbocisteine and hypertonic saline (a concentrated salt solution), have been used in hopes of making this process easier.
To test if these treatments actually worked, researchers conducted a large study involving nearly 2,000 critically ill patients who were at least 16 years old. These patients were struggling with severe breathing issues and had thick secretions that were difficult to clear. The researchers divided the group into different categories to see how carbocisteine alone, hypertonic saline alone, or a combination of both compared to standard care.
The results showed that neither carbocisteine nor hypertonic saline helped patients get off the ventilator any faster than the standard treatments provided. While doctors hoped these medications would clear the airways and shorten the time spent on machines, the data did not show a significant difference in how long it took for patients to breathe independently. In fact, both treatments were associated with specific risks.
Safety was a major finding of the study. Patients who received carbocisteine had a higher rate of serious stomach bleeding compared to those who did not receive it. Meanwhile, patients who received hypertonic saline faced a much higher risk of their airways narrowing (bronchoconstriction) and experiencing low oxygen levels during the treatment. These findings suggest that while these medications were intended to help, they may have caused harm without providing any extra benefit in terms of recovery speed.
It is important to remember that this was one study, and while it involved a large number of people, it does not change every medical protocol overnight. However, the results provide clear evidence for doctors to weigh the risks against the benefits. For now, these specific treatments are not shown to be more effective than standard care for clearing secretions in critically ill patients. Doctors will continue to use their best judgment to ensure patient safety while managing difficult-to-clear mucus.
